CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BSF Enterprise PLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BSF Enterprise PLC
Ground Floor, 31 Old Burlington Street
Phone: +44 2032834590p:+44 2032834590 LONDON, W1S 3AS  United Kingdom Ticker: BSFABSFA
Business Summary
BSF Enterprise PLC is a United Kingdom-based biotech company. The Company develops and commercializes cell-based tissue engineered solutions, including lab-grown leather, cultivated meat, and corneal repair technologies. The principal activity of the Company is to undertake the acquisition of businesses in the biotechnology, marketing and e-commerce sectors. The Company operates through its wholly owned subsidiaries, 3D Bio-Tissues Limited (3DBT), Lab Grown Leather Limited (LGL), Kerato Limited (Kerato), and BSF Enterprise (Hong Kong) Limited (BSF HK). 3DBT is a tissue engineering company developing processes and tools for others to create functional tissues from a range of cell types. This includes a platform for generating structured tissues as well as media supplements that can accelerate and increase cell performance. Kerato utilizes multi-patented technology with expertise in tissue engineering and biomaterials to develop bio-equivalent corneal tissue.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20259/30/2024Yes-Yes-Yes

Industries
SIC Code Description
2834 Pharmaceutical preparations
9999 Non-classified establishments

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board MinYang
Chief Executive Officer, Executive Director CheConnon 6/16/2022 6/16/2022
Executive Director, Company Secretary Geoffrey R.Baker
Independent Non-Executive Director Kian JingOw

Business Names
Business Name
BSFA
BSFAF

General Information
Number of Employees: 4 (As of 9/30/2024)
Outstanding Shares: 123,649,437 (As of 3/31/2025)
Stock Exchange: LON
Federal Tax Id: 812224826


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, August 12, 2025